RandyW Posted November 28, 2007 Share Posted November 28, 2007 BATON ROUGE, La., Nov. 27 /PRNewswire-USNewswire/ -- More than 700 medicines for diseases that disproportionately or only affect women are currently in development, according to a new report released today at an event in Baton Rouge, Louisiana by the Pharmaceutical Research and Manufacturers of America (PhRMA). America's pharmaceutical research companies are developing new medicines to fight arthritis, women-specific cancers, diabetes, obstetric/gynecologic conditions and mental illnesses that, at the very least, impair the quality of life for women. "There is significant progress being made in the search for new cures and treatments for diseases of special concern to women," said Billy Tauzin, President and CEO of PhRMA. "We are looking to a future where more women can lead long and healthy lives. These drugs that are now in development are helping get us there." According to the report, the drugs in development include: -- 135 medicines for cancers disproportionately affecting women; including 95 for breast cancer, 47 for ovarian cancer and 17 for cervical cancer. This year, more than 700,000 cases of these three cancers alone will be diagnosed, according to the American Cancer Society. -- 125 medicines for arthritis and musculoskeletal disorders. Arthritis affects 41 million American women; accounting for 70 percent of all rheumatoid arthritis suffers, according to the Society of Women's Health research. -- 106 medicines for autoimmune disorders, which collectively afflict 23.5 million Americans, most of them women, according to National Institute of Allergy and Infectious Diseases. Other medicines in development include treatments for diabetes, glaucoma, irritable bowel syndrome, urinary tract infections, asthma, Alzheimer's disease, migraine, obstetric and gynecologic conditions, depression, anxiety, and sepsis - all of which disproportionately affect American women. In separate reports, PhRMA has found that researchers are working on 277 medicines for heart disease and stroke - which kill half a million women each year - and 96 medicines for lung cancer, the leading cancer killer of women. To view the report and other information about medicines in development for infectious diseases, go to: http://www.phrma.org/ The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry wide research and investment reached a record $55.2 billion in 2006. PhRMA Internet Address: http://www.phrma.org/ For information on stories of hope and survival, visit: http://sharingmiracles.com/ For information on how innovative medicines save lives, visit: http://www.innovation.org/ For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org/ For information on the danger of imported drugs, visit: http://www.buysafedrugs.info/ Pharmaceutical Research and Manufacturers of America Copyright © 2007 PR Newswire. All rights reserved. Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.